Molecular Analysis of Constitutively Expressederm(C) Genes SelectedIn Vitroby Incubation in the Presence of the Noninducers Quinupristin, Telithromycin, or ABT-773
- 1 September 2002
- journal article
- research article
- Published by Mary Ann Liebert Inc in Microbial Drug Resistance
- Vol. 8 (3) , 171-177
- https://doi.org/10.1089/107662902760326878
Abstract
A Staphylococcus aureus strain that harbored a plasmid-borne inducibly expressed erm(C) gene was cultivated in the presence of the noninducers quinupristin, telithromycin, and ABT-773. After overnight incubation, 78 mutants that displayed combined resistance to macrolides, lincosamides, streptogramin B antibiotics, and ketolides were analyzed for the genetic basis of this altered resistance phenotype. Because this resistance phenotype is indicative for constitutively expressed erm(C) genes, the erm(C) regulatory regions of all mutants were sequenced. All 78 mutants showed sequence alterations in the erm(C) translational attenuator. Seventeen different types of sequence deletions ranging from 5 bp to 121 bp and nine different types of tandem duplications of 13-100 bp, all causing constitutive erm(C) gene expression, were detected. These sequence deletions or tandem duplications either favored the formation of mRNA secondary structures in the erm(C) translational attenuator, which did not inhibit translation of the erm(C) transcripts, or completely prevented the formation of any mRNA secondary structures in the erm(C) translational attenuator. The mean frequencies of 10-6 to 10-8 by which constitutive mutants were obtained, strongly suggest that telithromycin and ABT-773 not be recommended for the treatment of staphylococci that exhibit the inducible MLSB phenotype.Keywords
This publication has 27 references indexed in Scilit:
- Comparative In Vitro Activity of ABT-773, a Novel Antibacterial KetolideAntimicrobial Agents and Chemotherapy, 2001
- Prevalence of resistance to MLS antibiotics in 20 European university hospitals participating in the European SENTRY surveillance programmeJournal of Antimicrobial Chemotherapy, 1999
- In-vitro activity of the new ketolide antibiotic HMR 3647 against gram-positive bacteria.Journal of Antimicrobial Chemotherapy, 1998
- Comparative in-vitro activity of ketolide HMR 3647 and four macrolides against gram-positive cocci of known erythromycin susceptibility statusJournal of Antimicrobial Chemotherapy, 1998
- Insights into erythromycin action from studies of its activity as inducer of resistanceAntimicrobial Agents and Chemotherapy, 1995
- pRj5: a naturally occurring Staphylococcus aureus plasmid expressing constitutive macrolide--lincosamide--stireptogramin B resistance contains a tandem duplication in the leader region of the ermC geneJournal of General Microbiology, 1993
- Bacterial resistance to macrolide, lincosamide, and streptogramin antibiotics by target modificationAntimicrobial Agents and Chemotherapy, 1991
- A Staphylococcus aureus plasmid that specifies constitutive macrolide-lincosamide-streptogramin B resistance contains a novel deletion in the ermC attenuatorFEMS Microbiology Letters, 1990
- Translational Attenuation: The Regulation of Bacterial Resistance to the Macrolide-Lincosamide-Streptogramin B AntibioticCritical Reviews in Biochemistry, 1984
- Macrolide Resistance in Staphylococcus aureus : Inducers of Macrolide ResistanceAntimicrobial Agents and Chemotherapy, 1977